Search results

BeOne Medicines is a global oncology company developing innovative, affordable, and accessible cancer treatments worldwide. We expedite development of our diverse pipeline of novel therapeutics through strong internal capabilities and collaborations. Our 11,000 colleagues span six continents.

Justin Stindt Consultants is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industries.

The Nikon Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and academia with industry leading microscope-based imaging solutions. In addtion the Nikon BioImaging Lab, is a CRO that provides microscope-based imaging and analysis services.

We are offering worldwide professional medical writing and related services to the pharmaceutical (human & veterinary), biotech, medical device and other industries, CROs and academic institutions. With over 20 years of experience in the field, we guarantee the best possible medical writing.

Skyvor Medical is a Basel-based digital health company, founded by seasoned professionals with 35 years of drug development experience in global pharma. Skyvor Medical develops AI-powered digital platforms to accelerate the protocol design, feasibility and data management in clinical trials.

Founded in mid-2022, T-Oncology is a Swiss biotech startup dedicated to transforming cancer treatment through innovative therapies. Our Mission: Give hope to patients by creating advanced therapeutics that offer safe and more effective treatment options, affordable for patients worldwide.

Amporin is developing a new class of small molecule amyloid pore inhibitors as the first potential acute oral drugs to stop and reverse the progression of deadly degenerative diseases. Our vision is to cure 6 major degenerative diseases with a simple pill, starting with Parkinson’s disease.

Procavea Biotech is an ETH Spin-off company developing an innovative protein-based RNA delivery platform. Our focus is to generate siRNA therapeutics in extrahepatic disease areas that are currently unreachable.

Prasfarma is a Pharmaceutical Company that operates as a CMO and CDMO) with experience in cytostatics, high potency products and biologics. Our flexibility & state of the art technologies, make us the ideal partner for small productions or R&D projects (pilot plant) and commercial supply (factory).

Access2Health partners with biotechs, providing flexible, cost-effective support to maximise asset value. We offer strategic guidance in market potential, evidence generation, pricing, and value strategy, helping biotech leaders make informed decisions that strengthen their position with investors.

ICE Biopharma has 2 core businesses: in-licensing specialty and rare disease drugs for Europe and Canada, and operational consultancy to companies evaluating international Commercialization options. We want European and Canadian patients to have access to the breakthrough therapies they deserve.

ANSEA is a global consulting firm enabling pharmaceuticals, biopharmaceuticals and medical device companies navigate through the complexities of healthcare systems across the world and helping bring their solutions to patients.

Cradle’s mission is to make engineering biology easier, quicker and more cost-effective. Its enterprise-grade AI software helps scientists engineer better proteins, faster and more successfully, speeding up the development cycle of new therapeutics and bio-based products. Learn more at cradle.bio.

Xcube.bio builds organizations with late-stage innovative biopharma companies to enable the European market entry of life changing therapies. We create partners' own commercial footprint and revenue streams. Unique value proposition that open and de-risk the European market for innovative therapies.

Chelonia  is a Swiss innovation and AI strategy firm designing data-driven frameworks that translate scientific knowledge into real-world solutions. We integrate complex biological, clinical, and environmental data into deployable and explainable systems.

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Complyomics supports Life Sciences companies in core areas as: Build and maintain robust Quality Systems in compliance with regulatory requirements. Provide externalized QA. Audits Develop expertise in Bioanalytical / Analytical areas Identify / assess / supervise sub-contractors Due diligence

Tandem Therapeutics (Spin-off ETH Zurich & PSI) is tackling the growing unmet medical need in treating fibrosis with precision extracellular matrix targeting. Our novel peptide drug conjugates selectively target mechanical changes in the fibrotic extracellular matrix to potentially halt progression.

ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.

HekeTiss, a UNIGE/HUG spin-off, enhances lives by pioneering cell-therapy treatments for ulcerative skin conditions. Innovating for a healthier tomorrow.

We build true longevity by turning proven drugs into patient-friendly, affordable prescription medicines. With our ORASMART® platform technology, we scale from an initial focus on two indications to more than 30 longevity therapies across metabolic diseases, chronic care, and beyond.

FatiAbGen International is the Swiss subsidiary of FatiAbGen Inc., established in Korea in 2020. We engineer best in class antibodies tailored for multiple modalities such as ADCs and bi-specifics. We then develop targeted molecules to address high unmet need diseases in oncology and immunology.

NewBiologix is a company developing a proprietary and breakthrough platform for the advanced engineering of cell lines. The company is committed to improving the production of viral vectors used in gene therapy by combining an innovative bioinformatics platform with advanced R&D experimentation.

Apricot BIO is a first-time launcher of a Functional Precision Oncology platform performing deep molecular phenotyping of drug responses for personalised therapy recommendations for early to late-stage clinical decision-making leading to more precise, evidenced-based recommendations for doctors.

Remora Biotech is a biotherapy portfolio company with a track record of successfully turning science into life-changing biotherapies. We focus on high-impact therapeutic areas including oncology, immunology, regenerative / aesthetic medicine and cell and gene therapies.

We are managing a portfolio of biotech opportunities, each selected based on promising science and potential for addressing unmet medical needs. Our team of industry-leading experts has extensive development & biotech experience which we put into practice to accelerate science into care.

Alpha Lyncis SA is a Swiss-based service provider supporting implementation and transfer of biotechnological and chemical production processes. We complement our customers teams to develop holistic solutions for manufacturing challenges and accelerate the success of highly regulated products.

Luminance Health is a premium life science consultancy providing personalized support across the entire value chain. We provide cross-functional strategic and hands-on support to develop, register, market and bring innovative products to market.

Curie.Bio is a $1.2B VC founded to discover and develop important new medicines. We do that by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. Our team of >100 full-time drug hunters provides hands-on support to founders.

TIBIO is a Swiss environmental biotechnology and scientific consulting company founded in 2009 and active in the fields of: Scientific consulting and R&D project management. Chemical, microbiological and toxicological analysis. Provision of solutions for environmental pollution problems.

DIAMANTE is a boutique business and management consulting company dedicated to biotech and pharma clients, diagnostics companies and investors in healthcare. We support companies to streamline product design and development, and work with investors to accelerate and de-risk their selected assets.

APR Applied Pharma Research s.a. (wholly owned by Relief Therapeutics Holding AG, SIX: RLF.SW), is a B2B Swiss-based international biopharma focused on development and global commercialization of innovative, patent protected products designed to address unmet needs.

At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.

Quant Biomarkers develops next-gen urinary biomarkers for cardio-kidney-metabolic diseases. Its RenoRisk™ test detects kidney injury 3–6 years earlier than standard markers, supported by AI software for improved risk stratification, monitoring, and management.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.

chAIron blends AI with deep life-science expertise to accelerate R&D. We identify and prioritize new indications, strengthen evidence, de-risk development decisions, and unlock the full potential of pharma and biotech assets—helping deliver better outcomes for patients.

MaxWell Biosystems is an electronics-focused life-science company based in Zurich, Switzerland, developing and selling high-content electrophysiology platforms to help our customers in the pharmaceutical industry and in academia make their drug discovery and research more efficient.

Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics. Established in 2003, MBH's mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies. Our Q system complies with AIFA/EU GMP requirements.

Our mission is to develop novel formulations for biological drugs enabling direct and exclusive delivery to diseased cells and tissues. Our concept for the oligonucleotide drug family of siRNAs creates a broad potential for this new generation of drugs, having recently emerged in the drug landscape.

At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.

Salvina Therapeutics is developing antibodies with a novel approach for targeting TNF and TNF superfamily members with the aim of improving their safety and efficacy, and facilitating the generation of novel bispecific therapies.

Oryl Photonics has developed a groundbreaking laboratory instrument for solubility and aggregation measurement. It is the world's first accurate and rapid solubility testing solution that saves precious drug compounds.

ONtrack Biomedical AG is a Swiss spin-off of the University Zurich and University Hospital Zurich which develops in-vitro diagnostic tests for the early and non-invasive detection and monitoring of cancer. Our first product is a urine test for the early detection and monitoring of prostate cancer.

Swiss Deeptech developing AI-driven hardware & software measuring aging hallmarks, starting with telomeres via our single-cell & nucleotide-resolution technologies.We leverage these to generate actionable datasets for diagnostics, stratification and drug discovery in idiopathic age-related diseases.

Porton Pharma Solutions, a global company with R&D, and GMP-compliant manufacturing facilities across US, EU and China, provides customer-centric innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (ADCs, PDCs, etc.) from pre-clinical to commercial stage.

FinalSpark is at the forefront of technological innovation, pioneering the development of bioprocessors — the next generation of digital processors. These groundbreaking bioprocessors utilize human neurons instead of traditional silicon, marking a significant leap in processing technology.

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.

iCure offers the Cardinal platform for developing digital health applications that comply with cybersecurity standards, with end-to-end encryption, FHIR interoperability, and open-source SDKs, accelerating innovation in e-health. iCure is ISO27001, ISO13485, HDS certified, GDPR and NIS2 compliant.

RDP Pharma (RDP) is a privately held biotech, dedicated to the vision that their products will deliver valuable medicines to patients in need. RDP’s leadership team and board of directors are focused on getting their products into clinical trials and addressing the unmet medical needs of patients.

Altorfer Engineering is a specialized contractor and consulting company. We provide expertise in engineering and project management services, and technology transfers. Our focus is on developing and managing aseptic formulation and fill-finish processes tailored to your receiving sites.

The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institute that has been at the forefront of translational research for over 90 years. Leveraging the strength of its research centers, JAX offers drug developers innovative preclinical platforms and services.

Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.

Olgram develops new drugs to cure immune deficiencies for which there are no satisfactory therapeutic solutions. Our 1st clinical application is immunodepression post traumatic brain injury, affecting 5 million people. We also develop new anti-infectious to cure the chronic bacterial infection.

Infinity Communications works with start-up and growth-stage healthcare companies to deliver insights-driven, strategic communications. We add value by developing content and material to raise your company profile, attract new investors and engage audience groups across the health ecosystem.

LabForce AG is a Swiss company, founded in January 1999. We have the largest portfolio of antibodies, proteins and assay kits in Switzerland accomplished by innovative and best-in-class laboratory equipment in the field of cellular and molecular biology.

B Squared helps biotech and cell & gene therapy companies navigate complex CMC, manufacturing, and sourcing challenges. We bring hands-on expertise, real-world solutions, and a no-nonsense approach to getting things done.

Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.

Swiss Bioscience was established in 2014 in Switzerland and is specialized in producing pharmaceutical quality grade stems cells under cGMP* conditions. The cells are isolated from human adipose tissue to produce SVF which is then purified and expanded to produce hADSCs.

CELLnTEC technologies enable science and industry to develop innovations in stem cell research, regenerative medicine, cell-based therapies, and beyond. The company is a pioneering developer of chemically defined, animal and human components-free precision media.

Caland SA provides a professional, confidential, competitive and impeccable service of pharma-grade CO2 extraction, distillation and cannabis formulation based on GMP requirements. A modern production line, coupled to a qualified ERP, ensures uncompromising quality of all products and services.

We at INCAPTEK are developing advanced drug delivery systems. We deliver drugs at the right place, in the right dosage, and at the right time. Our smart, programmed-shell micro(nano)capsules can be used for controlled and targeted drug delivery for both biotech and medtech.

Curare specializes in translational and clinical pharmacology, increasing confidence in therapeutics translation from the bench to clinical proof‑of‑concept, and enhancing early stage decision-making. Expertise tailored to your needs, from small biotech to pharma.

MRGN Advisors was established in 2015 to advise CEOs, boards and investors on portfolio strategy, commercial and market access development, partnering and investment advisory in pharma, biologicals, vaccines, med tech and healthcare IT. Our motto: Even monkeys fall from trees — Japanese Proverb

Our goal is to deliver innovations in health care through cutting-edge tech and research, addressing challenges in antimicrobial therapies to improve patient outcomes. We are committed to delivering superior treatments that promote healing and improve quality of life globally.

Rambam AG is a Swiss-based venture studio and accelerator platform for breakthrough drug discovery and development. Our portfolio of companies and programs is supported by a core group of seasoned industrial experts, PMs and dedicated functional experts from Switzerland, Portugal, Germany and the US.

Floratek Pharma is focused on drug discovery and preclinical development, enhancing the healing power of plants through the optimisation of existing natural compounds. The company pipeline comprises of anti-cancer and neurodegenerative disorder therapies as well as anti-aging dietary enhancements.

I work closely with my clients as a freelance science business development project manager. That said, Boehler Life Science Advice is not a typical consultancy, even though strategic planning and execution are important elements of how I support my clients.  

Qanatpharma (QP) is a Swiss clinical-stage biotech pioneering resistance artery medicine. Our Arteriome platform combines vascular biology, functional phenotyping and AI to discover novel drug targets and develop therapeutics for cardiovascular and neurological diseases.

Orio Therapeutics developed a technology based on protein engineering allowing to integrate a "built-in" delivery systems into any therapeutic protein. Orio Therapeutics has set as a priority for their first product the development of a cardioprotective drug for heart attack patients.

VACCENTIS AG is a Zurich-based investment company focused on the biotech and pharmaceutical sector. The entire research, production and sales activities are carried out by two highly specialized subsidiaries, VCC MEDICAL and FBM-Pharma, which focus on special methods of personalized medicine.

InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricate novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).

Outsourcing, Supply Chain & Development Operations Experts and Solutions for Innovative Biotechs & Medtechs. Kisco gives access to teams of seasoned experts to support the development cycle, from Clinical Research (CRO), Supply Chain set up, Outsourced Manufacturing (CMC, CDMO), and R&D Operations

Provectis Healthcare AG is a global healthcare company based in Basel and the commercial partner of choice to the innovative biopharma. We advance the innovation through launch, commercialization and brand building in Europe, Middle East and Asia.

7AlpsBio Consulting Services offers expertise in healthcare in strategic, operational, project support and a management know-how with a focus on ATMPs, biopharmaceuticals and life sciences in (pre)clinical development, GMP manufacturing from clinical trials to commercialization.

FimmCyte is developing disease modifying therapies for chronic diseases through the direct elimination of diseased cells. FimmCyte has a pipeline of assets two of which are about to begin IND enabling studies, one for endometriosis and the second for organ fibrosis.

Phialogics is a preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation.

Tenpoint Therapeutics is a global, clinical-stage biotech company developing treatments to rejuvenate vision in the aging eye. Its pipeline includes treatments for ophthalmic indications with the greatest need and global market potential, including presbyopia, cataracts and geographic atrophy.

Amphilix AG is a Basel-based biotech developing next-generation radioligand therapies using a proprietary 3D linker platform and small-molecule ligands. Its clinical-stage lead AMX-0053 targets a protein for colorectal cancer and is ready for First-in-Human imaging. The company seeks CHF 9m Seed.

Toxicology Consultant with >25 years of experience in the Biopharmaceutical Industry. I support Startup and Biotech Companies to advance their projects into the clinical phase. Get in touch to discuss your project when you have a shortage of nonclinical and toxicological expertise.

Oncodesign Services is a leading CRO specializing in drug discovery and preclinical services in (immuno-)oncology, autoimmune, inflammation and infectious diseases, through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vitro/in vivo pharmacology.

Eviden is an Atos business that brings together its digital, cloud and big data & security business lines. It will be a global leader in data-driven, trusted and sustainable digital transformation.

We identified a novel immuno-oncology target through bacterial metabolites that activate tumor-residing macrophages, triggering a potent anti-tumor response. By leveraging natural metabolic processes, we develop small molecule therapies to enhance the body’s native immune defense against cancer.

ACM Biosciences AG is a subsidiary of ACM Biolabs PTE Ltd. Singapore. Its purpose is to internationalise its development activities. It leads all clinical and regulatory activities of its pipeline programs and coordinates business development discussions with potential partners.

We are focusing on worldwide sourcing,distributing and custom manufacturing of fine chemicals, intermediates, ingredients, specialities, niche APIs and NCE’S since 1997.

Cellerys AG is a clinical stage biotechnology company, developing immune tolerance therapeutics for the treatment of multiple sclerosis (MS). Antigenic peptides identified from MS patients are coupled to autologous red blood cells which, when reinfused, restore immune tolerance. in 2021 the company entered a

Preclinical safety/toxicology and strategic regulatory consulting for biotech start-ups, with a focus on supporting prgrams from preclinical development to first-in-human trials.  

We are an independent biotech company based in Ticino. We focus on generation, development and characterization of nanobodies produced from proprietary, rationally engineered human libraries relevant to enhance the R&D pipeline of partners and clients.

Volv Global is a healthcare AI company founded in 2017, generating new knowledge at speed to close diagnostic and care pathway gaps – enabling earlier diagnosis and better outcomes for patients with difficult-to-diagnose diseases, with data partners spanning 400 million patients worldwide.

Alloy Therapeutics is a biotechnology ecosystem company democratizing access to tools, technologies, and services for discovering and developing therapeutic biologics across six modalities, including antibodies, TCRs, genetic medicines, peptides, cell therapy, and drug delivery.

NexMR is a Magritek company providing benchtop NMR solutions to Pharma, Biotech, and Life Science companies. We provide enterprise customer support for benchtop NMR implementation across diverse workflows in the industry: radiochemistry, reaction monitoring, flow chemistry, PAT, screening, and more.

EvlaBio is a life science startup dedicated to the development of first-in-class therapeutics in the cardiovascular and cardiorenal space. The lead asset is a Therapeutic Monoclonal Antibody (mAb) targeting unphysiological FGFR4/FGF23 cardiac overdrive in the setting of chronic kidney disease (CKD).

MEDICE has always developed and produced medicinal products almost exclusively at the Iserlohn site and concentrates in the prescription area on CNS, renal medicine and dialysis medicine. Salmon Pharma is the Swiss subsidiary of MEDICE.

We are specialized in processes optimization and validation, GMP and ISO compliance aspects, quality systems, risk analysis, CE marking, equipment qualification, project management, etc.

Azafaros is a clinical-stage biotech company addressing rare genetic lysosomal storage disorders with oral small molecules, including nizubaglustat. Our focus is on developing disease-modifying therapies for patients with, among others, GM1 and GM2 gangliosidoses, and Niemann-Pick Type C disease.

AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. The co-founders of AlphaMol are leading scientists in the area of GPCRs. Many essential molecular mechanisms and biotechnology were invented by the members of AlphaMol.

PDC Therapeutics is a clinical-stage biotech start-up developing targeted Polymer-Drug Conjugate technologies with an optimal therapeutic index. The proprietary Sagitta® biodegradable conjugation platforms help discover and develop therapies with no compromise with a versatile targeting capability.

Pheida develops and deploys biotech solutions at scale to reduce GHG emissions and other pollutants, and to remediate contaminated soil and water. Pheida products combine advanced biotech, proprietary application engineering to deliver unique and commercially attractive solutions.

Founded in 2018, Peptone specializes in novel therapeutics for Intrinsically Disordered Proteins (IDPs), linked to inflammatory diseases such as cancer. Their approach integrates biophysics, supercomputing, and machine learning, now advancing in their labs.

SEAL Therapeutics develops an innovative gene therapy approach that overcomes the functional defects causing LAMA2-related muscular dystrophy. The approach involves AAV-based delivery of specifically designed artificial linker proteins to compensate for the missing laminin-alpha 2 in muscle fibers.